Quinoxaline Derivatives as Antitumor Agents

Details for Australian Patent Application No. 2006208084 (hide)

Owner The Trustees of Columbia University in the City of New York Prolexys Pharmaceuticals, Inc. Whitehead Institute for Biomedical Research

Inventors Qi, Longwu; Simmons, Keith; Robbins, Paul B.; Stockwell, Brent R.; Chepanoske, Cindy Lou; Sahasrabudhe, Sudhir R.; Venkat, Raj Gopal; Pelter, John M.; Selliah, Robert; Von Rechenberg, Moritz; Becklin, Robert R.; Zhen, Eugene

Agent Shelston IP

Pub. Number AU-B-2006208084

PCT Pub. Number WO2006/081331

Priority 60/762,221 24.01.06 US; 60/647,303 25.01.05 US

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 26 July 2012

International Classifications

C07D 239/90 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 Antineoplastic agents

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081331 Priority application(s): WO2006/081331

4 October 2007 Change of Name(s) of Applicant(s), Section 104

  Whitehaed Institute for Biomedical Research; The Trustees of Columbia University in the City of New York; Prolexys Pharmaceuticals, Inc. The name of the applicant has been changed to The Trustees of Columbia University in the City of New York; Prolexys Pharmaceuticals, Inc.; Whitehead Institute for Biomedical Research

22 April 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Quinoxaline Derivatives as Antitumor Agents 2006230531 BP Corporation North America Inc. The nature of the amendment is: Amend the invention title to read Process for removing color bodies from hydrocarbon-based fuels using activated carbon

26 July 2012 Application Accepted

  Published as AU-B-2006208084

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208087-Process for preparing substituted 1- [3- ( pyrazolyl) phenyl] -3-phenyl ureas

2006208080-Video-assisted laryngeal mask airway devices